Altogether, these findings emphasize the pivotal role of NF-κB in leukemogenesis, and indicate that this pro-inflammatory factor is activated by epigenetic regulation in HMs originating from primary lymphoid organs such as leukemias and myeloma. The gene discussed is NFKB1; the disease is plasma cell myeloma.